Fourth quarter revenue expected to be $15.9 million to$16.1 million, representing growth of 4% to 5%Full year revenue expected to be $56.5 million to$56.7 million, representing growth of 10% to 11%Fiscal 2026 revenue expected to be between $63 million and$67 million, representing growth of 11% to 18%Category I CPT codes and the related favorable physician fee payment levels took effect on Jan. 1, 2026FDA approved the BENEFIT-HF trial design in November and the Company has since applied to CMS for coverag ...